GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Tenet Healthcare Corp (NYSE:THC) » Definitions » EV-to-EBIT

Tenet Healthcare (Tenet Healthcare) EV-to-EBIT

: 9.25 (As of Today)
View and export this data going back to 1976. Start your Free Trial

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Tenet Healthcare's Enterprise Value is $23,296 Mil. Tenet Healthcare's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $2,518 Mil. Therefore, Tenet Healthcare's EV-to-EBIT for today is 9.25.

The historical rank and industry rank for Tenet Healthcare's EV-to-EBIT or its related term are showing as below:

THC' s EV-to-EBIT Range Over the Past 10 Years
Min: 7.23   Med: 15.43   Max: 50.18
Current: 9.25

During the past 13 years, the highest EV-to-EBIT of Tenet Healthcare was 50.18. The lowest was 7.23. And the median was 15.43.

THC's EV-to-EBIT is ranked better than
79.39% of 427 companies
in the Healthcare Providers & Services industry
Industry Median: 18.27 vs THC: 9.25

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Tenet Healthcare's Enterprise Value for the quarter that ended in Dec. 2023 was $25,227 Mil. Tenet Healthcare's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $2,518 Mil. Tenet Healthcare's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 9.98%.


Tenet Healthcare EV-to-EBIT Historical Data

The historical data trend for Tenet Healthcare's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tenet Healthcare Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBIT
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.95 12.17 8.99 10.15 10.02

Tenet Healthcare Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-EBIT Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.15 10.74 11.12 10.55 10.02

Competitive Comparison

For the Medical Care Facilities subindustry, Tenet Healthcare's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tenet Healthcare EV-to-EBIT Distribution

For the Healthcare Providers & Services industry and Healthcare sector, Tenet Healthcare's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Tenet Healthcare's EV-to-EBIT falls into.



Tenet Healthcare EV-to-EBIT Calculation

Tenet Healthcare's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=23295.892/2518
=9.25

Tenet Healthcare's current Enterprise Value is $23,296 Mil.
Tenet Healthcare's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $2,518 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Tenet Healthcare  (NYSE:THC) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Tenet Healthcare's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 ) =EBIT / Enterprise Value (Q: Dec. 2023 )
=2518/25227.2215
=9.98 %

Tenet Healthcare's Enterprise Value for the quarter that ended in Dec. 2023 was $25,227 Mil.
Tenet Healthcare's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $2,518 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Tenet Healthcare EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Tenet Healthcare's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Tenet Healthcare (Tenet Healthcare) Business Description

Traded in Other Exchanges
Address
14201 Dallas Parkway, Dallas, TX, USA, 75254
Tenet Healthcare is a Dallas-based healthcare services organization. It operates a collection of hospitals (about 60 as of June 2023) and over 550 ambulatory surgery centers and other outpatient facilities across the U.S., primarily in the South. Through its Conifer segment, Tenet also provides revenue cycle management solutions.
Executives
Richard W Fisher director
Roy Blunt director 2702 LOVE FIELD DRIVE, HDQ 4GC, DALLAS TX 75235
Paola M Arbour officer: EVP, Chief Information Officer 14201 DALLAS PARKWAY, DALLAS TX 75254
Stephen H Rusckowski director C/O QUEST DIAGNOSTICS, 500 PLAZA DRIVE, SECAUCUS NJ 07094
Thomas W Arnst officer: EVP, Chief Admin. Officer & GC 14201 DALLAS PARKWAY, DALLAS TX 75254
Tammy Romo director C/O SOUTHWEST AIRINES CO., 2702 LOVE FIELD DR., DALLAS TX 75235
Daniel J Cancelmi officer: Principal Accounting Officer 13737 NOEL ROAD, SUITE 100, DALLAS TX 75240
J Robert Kerrey director NEW SCHOOL UNIVERSITY, 66 W. 12TH STREET, NEW YORK NY 10036
Richard J Mark director 1901 CHOUTEAU AVENUE MC-1310, ST. LOUIS MO 63103
Ronald A Rittenmeyer director 5400 LEGACY DRIVE, PLANO TX 75024
Lisa Y Foo officer: EVP, Commercial Ops 14201 DALLAS PARKWAY, DALLAS TX 75254
Audrey T. Andrews officer: SVP and General Counsel 1445 ROSS AVENUE, SUITE 1400, DALLAS TX 75202
Meghan Fitzgerald director C/O VION PHARMACEUTICALS, INC., 4 SCIENCE PARK, NEW HAVEN CT 06511
Howard Hacker officer: EVP, Chief Compliance Officer 14201 DALLAS PARKWAY, DALLAS TX 75254
Marie Quintana officer: EVP, Marketing/Communications 14201 DALLAS PARKWAY, DALLAS TX 75254